Market Place
Sourcing Support
Synthon`s Generics Glatiramer Acetate Receives Approval in US
25 Sep 2024 //
FDA
Synthon Pharma`s Generics Glatiramer Acetate Receives Approval in US
25 Sep 2024 //
FDA
Synthon Pharms Generic Palbociclib Receives Approval in US
05 Jun 2024 //
FDA
Synthon Pharma`s Generic Gefitinib Receives Tentative Approval In US
27 Nov 2020 //
FDA
Byondis Initiates Ph I Study of ADC [Vic-]Trastuzumab Duocarmazine + Niraparib
24 Aug 2020 //
PRESS RELEASE
Synthon Biopharmaceuticals Relaunches as Byondis
15 Apr 2020 //
BUSINESSWIRE
Fentanyl : Insys Therapeutics vs. Teva Pharmaceutical
24 Nov 2018 //
PATENT LITIGATION
Pomalyst® (Pomalidomide Capsules) : Celgene Corporation v. Synthon
21 Jun 2018 //
PATENT LITIGATION
US FDA grants fast track status to Synthon’s trastuzumab duocarmazine
01 Feb 2018 //
PHARMABIZ
Synthon`s generic version of Copaxone 40mg approved in Europe
06 Oct 2017 //
IN PHARMATECHNOLOGIST
Regulatory approval in Europe granted for Synthon`s Glatiramer Acetate
05 Oct 2017 //
BIOSPECTRUM
Updated: Copaxone Generics: Who Will Win First Filer Exclusivity?
04 Oct 2017 //
RAPS
Synthon says EPO appeal board has revoked Copaxone API patent
13 Sep 2017 //
IN PHARMATECHNOLOGIST
Copaxone (Glatiramer acetate): Teva v. Synthon Pharmaceuticals & Pfizer
07 Apr 2017 //
PATENT LITIGATION
Momenta says Pfizer will fix plant but reiterates that Glatopa 40mg ANDA delay
22 Feb 2017 //
IN PHARMATECHNOLOGIST
Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe
12 Apr 2016 //
CPHI ONLINE
Pfizer Grabs Commercialization Rights of Potential MS Generic Treatment Glatiramer Acetate
03 Aug 2015 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.